Indraprastha Medical Corporation shareholding pattern

INDRAMEDCO

384.5

9.20 (-2.34%)
Last updated on 4 Feb, 2026 | 13:54 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Indraprastha Medical Corporation Shareholding Pattern

  • 2016-17
  • 2018-19
  • 2019-20
  • 2021-22
  • 2020-21
  • 2025-26
  • 2024-25
  • 2022-23
  • 2023-24
Total Promoters
Segment
Percent

Total Promoters

51%

Mutual Fund

2.65%

Insurance

0%

Foreign Institutional Investors

2.88%

Domestic Institutional Investors

0.54%

Retail

42.93%

Others

0%

Total Promoters
MAR '24
51%
JUN '24
51%
SEP '24
51%
DEC '24
51%

Summary

For Year 2025-26, Indraprastha Medical Corporation reports the following shareholding: Total Promoters at 51%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 2.72%, Domestic Institutional Investors at 0.82%, and Retail at 45.44%. This breakdown provides a quick snapshot of ownership distribution for Indraprastha Medical Corporation in 2025-26.

Indraprastha Medical Corporation FAQs

As of 02-2026, the promoter shareholding in Indraprastha Medical Corporation stands at 51% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Indraprastha Medical Corporation is 2.72% and 0.82% respectively.

The retail shareholding of the Indraprastha Medical Corporation is 45.44%.

Changes in shareholding patterns of Indraprastha Medical Corporation can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Indraprastha Medical Corporation are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.